In vivo evaluation of pretargeted ⁶⁴Cu for tumor imaging and therapyLEWIS, Michael R; MU WANG; AXWORTHY, Donald B et al.The Journal of nuclear medicine (1978). 2003, Vol 44, Num 8, pp 1284-1292, issn 0161-5505, 9 p.Article

Nuklearmedizinische Aspekte in der Diagnostik und Therapie des Hodgkin-Lymphoms = Hodgkin's lymphoma in nuclear medicine: diagnostic and therapeutic aspectsSTAAK, J. O; DIETLEIN, M; SCHNELL, R et al.Nuclear-Medizin. 2003, Vol 42, Num 1, pp 19-24, issn 0029-5566, 6 p.Article

Development of ¹⁷⁰Tm-DOTA-cetuximab for radioimmunotherapySHIRVANI-ARANI, Simindokht; BAHRAMI-SAMANI, Ali; JALILIAN, Amir Reza et al.Journal of labelled compounds & radiopharmaceuticals. 2012, Vol 55, Num 3-4, pp 103-107, issn 0362-4803, 5 p.Article

Impact of nodal regression on radiation dose for lymphoma patients after radioimmunotherapyHARTMANN SIANTAR, Christine L; DENARDO, Gerald L; DENARDO, Sally J et al.The Journal of nuclear medicine (1978). 2003, Vol 44, Num 8, pp 1322-1329, issn 0161-5505, 8 p.Article

Three-dimensional dose model for the comparison of ¹⁷⁷Lu-HuCC49ΔCH2 and ¹⁷⁷lu-hucc49 radioimunotherapy in mice bearing intraperitoneal xenograftsROBERSON, Peter L; YOKOYAMA, Shigeru; ROGERS, Buck E et al.Cancer biotherapy & radiopharmaceuticals. 2003, Vol 18, Num 2, pp 239-247, issn 1084-9785, 9 p.Article

Radiation dosimetry results from a Phase II trial of ibritumomab tiuxetan (Zevalin) radioimmunotherapy for patients with non-Hodgkin's lymphoma and mild thrombocytopeniaWISEMAN, Gregory A; LEIGH, Bryan R; WHITE, Christine A et al.Cancer biotherapy & radiopharmaceuticals. 2003, Vol 18, Num 2, pp 165-178, issn 1084-9785, 14 p.Article

Additional radiation absorbed dose estimates for Zevalin radioimmunotherapyWISEMAN, Gregory A; LEIGH, Bryan R; DUNN, William L et al.Cancer biotherapy & radiopharmaceuticals. 2003, Vol 18, Num 2, pp 253-258, issn 1084-9785, 6 p.Article

A comparison of 4 radionuclides conjugated to antibodies for single-cell killMICHEL, Rosana B; BRECHBIEL, Martin W; MATTES, M. Jules et al.The Journal of nuclear medicine (1978). 2003, Vol 44, Num 4, pp 632-640, issn 0161-5505, 9 p.Article

Microdosimetric analysis of α-particle-emitting targeted radiotherapeutics using histological imagesAKABANI, Gamal; KENNEL, Stephen J; ZALUTSKY, Michael R et al.The Journal of nuclear medicine (1978). 2003, Vol 44, Num 5, pp 792-805, issn 0161-5505, 14 p.Article

Single-cell irradiation from [²¹¹At]astatine-labeled C215 monoclonal antibody: Improved estimates of radiosensitivity from measurements on cellular uptake and retentionPALM, Stig; BÄCK, Tom; CLAESSON, Ingela et al.Anticancer research. 2003, Vol 23, Num 2B, pp 1219-1221, issn 0250-7005, 3 p.Article

Beta dose-rate distributions in microscopic spherical tumors for intraperitoneal radioimmunotherapySYME, Alasdair; MCQUARRIE, Steve; FALLONE, B. Gino et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 5, pp 1495-1506, issn 0360-3016, 12 p.Article

Synergy between vascular targeting agents and antibody-directed therapyPEDLEY, R. Barbara; EL-EMIR, Ethaar; FLYNN, Aiden A et al.International journal of radiation oncology, biology, physics. 2002, Vol 54, Num 5, pp 1524-1531, issn 0360-3016, 8 p.Conference Paper

Radioimmunotherapy of non-Hodgkin's lymphoma with ⁹⁰Y-DOTA humanized anti-CD22 IgG (⁹⁰Y-epratuzumab): Do tumor targeting and dosimetry predict therapeutic response?SHARKEY, Robert M; BRENNER, Arnold; CZUCZMAN, Myron S et al.The Journal of nuclear medicine (1978). 2003, Vol 44, Num 12, pp 2000-2018, issn 0161-5505, 19 p.Article

Dosimetric analysis of radioimmunotherapy with ¹⁸⁶Re-labeled bivatuzumab in patients with head and neck cancerPOSTEMA, Ernst J; BÖRJESSON, Pontus K. E; OYEN, Wim J. G et al.The Journal of nuclear medicine (1978). 2003, Vol 44, Num 10, pp 1690-1699, issn 0161-5505, 10 p.Article

Vascular targeted endoradiotherapy of tumors using alpha-particle-emitting compounds: Theoretical analysisAKABANI, Gamal; MCLENDON, Roger E; BIGNER, Darrell D et al.International journal of radiation oncology, biology, physics. 2002, Vol 54, Num 4, pp 1259-1275, issn 0360-3016, 17 p.Article

Study of the clinical thermoluminescent dosimeter in the direct measurement of radiation absorbed dose for radioimmunotherapyCHIOU, R. K; WESSELS, B. W; WOODSON, M et al.International journal of radiation applications and instrumentation. Part A. Applied radiation and isotopes. 1991, Vol 42, Num 2, pp 181-186, issn 0883-2889Article

Radiobiology of radioimmunotherapy: Targeting CD20 B-cell antigen in non-Hodgkin's lymphomaHERNANDEZ, M. Carmen; KNOX, Susan J.International journal of radiation oncology, biology, physics. 2004, Vol 59, Num 5, pp 1274-1287, issn 0360-3016, 14 p.Article

Novel radiolabeled antibody conjugatesGOLDENBERG, D. M; SHARKEY, R. M.Oncogene (Basingstoke). 2007, Vol 26, Num 25, pp 3734-3744, issn 0950-9232, 11 p.Article

Clinical applications of newer radionuclide therapiesBRANS, Boudewijn; LINDEN, Ola; GIAMMARILE, Francesco et al.European journal of cancer (1990). 2006, Vol 42, Num 8, pp 994-1003, issn 0959-8049, 10 p.Article

Radioimmunotherapy of B-cell lymphoma with [¹³¹]anti-B1 (anti-CD20) antibodyKAMINSKI, M. S; ZASADNY, K. R; GLENN, S. D et al.The New England journal of medicine. 1993, Vol 329, Num 7, pp 459-465, issn 0028-4793Article

Comparison of ²¹¹At-PRIT and ²¹¹At-RIT of Ovarian Microtumors in a Nude Mouse ModelFROST, Sofia H. L; BÄCK, Tom; CHOUIN, Nicolas et al.Cancer biotherapy & radiopharmaceuticals. 2013, Vol 28, Num 2, pp 108-114, issn 1084-9785, 7 p.Article

Targeted molecular brachytherapyMAYORS, George L.Drug development research. 2006, Vol 67, Num 1, pp 94-106, issn 0272-4391, 13 p.Article

Advancing role of radiolabeled antibodies in the therapy of cancerGOLDENBERG, David M.Cancer immunology and immunotherapy. 2003, Vol 52, Num 5, pp 281-296, issn 0340-7004, 16 p.Article

Endoradiotherapy in cancer treatment: Basic concepts and future trendsZOLLER, Frederic; EISENHUT, Michael; HABERLCORN, Uwe et al.European journal of pharmacology. 2009, Vol 625, Num 1-3, pp 55-62, issn 0014-2999, 8 p.Article

Engineering a novel, stable dimeric streptavidin with lower isoelectric pointASLAN, Filiz M; YONG YU; VAJDA, Sandor et al.Journal of biotechnology. 2007, Vol 128, Num 2, pp 213-225, issn 0168-1656, 13 p.Article